Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Posters by Code

Type your Poster Code, then hit apply

Showing 1,267 results.

Thumbnail for National Trends in Pneumonia-Related Admissions Among Patients With Multiple Myeloma

MM - 826

National Trends in Pneumonia-Related Admissions Among Patients With Multiple Myeloma

Jackson Brunner

Poster Presenter: Jackson Brunner

Thumbnail for Allosteric NEK7 Inhibition With Ofirnoflast (HT-6184) Suppresses Mitochondrial Stress, Reduces Systemic Inflammatory Cytokines, and Attenuates Clonal Expansion in Lower-Risk Myelodysplastic Syndrome

MDS - 827

Allosteric NEK7 Inhibition With Ofirnoflast (HT-6184) Suppresses Mitochondrial Stress, Reduces Systemic Inflammatory Cytokines, and Attenuates Clonal Expansion in Lower-Risk Myelodysplastic Syndrome

Devan Bafna

Poster Presenter: Devan Bafna

Previous 1...64 65 66 67 68 69 70...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for ALOX5AP as an Oncogenic Regulator in Acute Myeloid Leukemia: Insights from Expression Profiling, DNA Methylation, and Molecular Pathway Analysis

AML - 828

ALOX5AP as an Oncogenic Regulator in Acute Myeloid Leukemia: Insights from Expression Profiling, DNA Methylation, and Molecular Pathway Analysis

Archit Goel

Poster Presenter: Archit Goel

Thumbnail for Comparison of Ivosidenib- and Venetoclax-Based Treatment Sequencing and Outcomes in Patients With mIDH1 AML: A Real-World Study

AML - 829

Comparison of Ivosidenib- and Venetoclax-Based Treatment Sequencing and Outcomes in Patients With mIDH1 AML: A Real-World Study

Vanessa Kennedy

Poster Presenter: Vanessa Kennedy

Thumbnail for Safety and Outcomes of Patients With Classical Hodgkin's Lymphoma Who Received Immune Checkpoint Inhibitors Before Autologous Stem Cell Transplantation: A Real-World Study

HL - 831

Safety and Outcomes of Patients With Classical Hodgkin's Lymphoma Who Received Immune Checkpoint Inhibitors Before Autologous Stem Cell Transplantation: A Real-World Study

Mohamad Baqer Skaini

Poster Presenter: Mohamad Baqer Skaini

Thumbnail for Update From the Phase 2 RESTORE Trial of Elritercept in Patients With Myelofibrosis Receiving Ruxolitinib

MPN - 832

Update From the Phase 2 RESTORE Trial of Elritercept in Patients With Myelofibrosis Receiving Ruxolitinib

Ciro Rinaldi

Poster Presenter: Ciro Rinaldi

Thumbnail for Circulating Extracellular Vesicle Profiles are Associated with the Development of Graft-versus-Host Disease Following Haematopoietic Stem Cell Transplantation

CT - 834

Circulating Extracellular Vesicle Profiles are Associated with the Development of Graft-versus-Host Disease Following Haematopoietic Stem Cell Transplantation

Rachel Crossland

Poster Presenter: Rachel Crossland

Thumbnail for Risk for Second Primary Malignancies in Patients With Hematologic Malignancies Receiving Bispecific Antibodies: A Real-World Analysis

CT - 835

Risk for Second Primary Malignancies in Patients With Hematologic Malignancies Receiving Bispecific Antibodies: A Real-World Analysis

Gaurav Periapattanam

Poster Presenter: Gaurav Periapattanam

Thumbnail for GLP-1 RECEPTOR AGONISTS ARE ASSOCIATED WITH SIGNIFICANTLY REDUCED ALL-CAUSE MORTALITY, HOSPITALIZATION, AND SEPSIS IN PATIENTS WITH MULTIPLE MYELOMA AND TYPE 2 DIABETES: A PROPENSITY-MATCHED ANALYSIS OF THE TRINETX GLOBAL COLLABORATIVE NETWORK.

MM - 837

GLP-1 RECEPTOR AGONISTS ARE ASSOCIATED WITH SIGNIFICANTLY REDUCED ALL-CAUSE MORTALITY, HOSPITALIZATION, AND SEPSIS IN PATIENTS WITH MULTIPLE MYELOMA AND TYPE 2 DIABETES: A PROPENSITY-MATCHED ANALYSIS OF THE TRINETX GLOBAL COLLABORATIVE NETWORK.

Mevlut Ozmen

Poster Presenter: Mevlut Ozmen

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.